Norges Bank’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-902,565
Closed -$12.7M 207
2025
Q2
$12.7M Hold
902,565
﹤0.01% 1243
2025
Q1
$21.7M Hold
902,565
﹤0.01% 1188
2024
Q4
$33.7M Buy
902,565
+139,042
+18% +$6.49M ﹤0.01% 1112
2024
Q3
$38.2M Sell
763,523
-17,147
-2% -$667K 0.01% 1065
2024
Q2
$27.1M Buy
780,670
+105,590
+16% +$4.18M ﹤0.01% 1136
2024
Q1
$36.9M Buy
675,080
+643,192
+2,017% +$31.8M 0.01% 1072
2023
Q4
$1.36M Buy
+31,888
New +$992K ﹤0.01% 1833
2023
Q2
Sell
-365,541
Closed -$4.99M 2023
2023
Q1
$4.99M Sell
365,541
-297,272
-45% -$4.73M ﹤0.01% 1757
2022
Q4
$9.2M Buy
+662,813
New +$9.36M ﹤0.01% 1599

Other funds holding BHVN

Norges Bank's BHVN Position: Q3 2025 in Review

Norges Bank sold out of Biohaven (BHVN) in Q3 2025, closing a stake of 902,565 shares — an estimated $12.7M sold.

Norges Bank first reported a position in BHVN in Q4 2022 and held it in 9 quarters. The position peaked at $38.2M in Q3 2024. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

  • Norges Bank reported no remaining Biohaven position as of Q3 2025 after selling out during the quarter.
  • Norges Bank sold 902,565 Biohaven shares in Q3 2025, an estimated $12.7M.
  • Norges Bank first reported a position in Biohaven in Q4 2022 and held it in 9 quarters.
  • Norges Bank's Biohaven position peaked at $38.2M in Q3 2024.
  • 264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.